Evidence map›Paper›PMID 35707143›Full record

ArticleACS medicinal chemistry letters2022

Latest Research Trends in Agrochemical Fungicides: Any Learnings for Pharmaceutical Antifungals?

Clemens Lamberth

Open access · greenAbstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Fungal Disease Tolerance with a Focus on Wheat: A Review.Journal of fungi (Basel, Switzerland) · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Clemens LamberthResearch Chemistry, Syngenta Crop Protection AG, Schaffhauserstrasse 101, CH-4332 Stein, Switzerland.ORCID https://orcid.org/0000-0002-4219-2739
Syngenta (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For a long time, fungal pathogens have been a threat to the health and diet of humans. Consequently, antimycotic agents have been developed, which are called fungicides in agriculture and antifungals in medicine. Because fungi constantly develop resistance to established modes of action and because of the need for reducing the required use rates/doses, immense research efforts are still being undertaken to discover novel antimycotics. The research-based agrochemical industry has proven that these requirements can be fulfilled by a constant flow of novel fungicidal modes of action, the expansion of agronomical scope and applicability of existing fungicidal mode of action classes, and the design of resistance-breaking active ingredients in an established fungicidal mode of action class, if the molecular structure of the mutated fungal strain is known. Such strategies could be also useful for the discovery of novel antifungals.

Identifiers

PMID35707143
PMCPMC9190031
OpenAlexW4280621995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.